Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Psychometric Evaluation of the Revised Iowa Pain Thermometer (IPT-R) in a Sample of Diverse Cognitively Intact and Impaired Older Adults: A Pilot Study.

Ware LJ, Herr KA, Booker SS, Dotson K, Key J, Poindexter N, Pyles G, Siler B, Packard A.

Pain Manag Nurs. 2015 Aug;16(4):475-82. doi: 10.1016/j.pmn.2014.09.004.

PMID:
26256217
2.

IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells.

Jen EY, Poindexter NJ, Farnsworth ES, Grimm EA.

Melanoma Res. 2012 Feb;22(1):19-29. doi: 10.1097/CMR.0b013e32834d2506.

3.

Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma.

Qin Y, Ekmekcioglu S, Liu P, Duncan LM, Lizée G, Poindexter N, Grimm EA.

Mol Cancer Res. 2011 Nov;9(11):1537-50. doi: 10.1158/1541-7786.MCR-11-0279. Epub 2011 Sep 27.

4.

Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome.

Khouri IF, Bassett R, Poindexter N, O'Brien S, Bueso-Ramos CE, Hsu Y, Ferrajoli A, Keating MJ, Champlin R, Fernandez-Vina M.

Cancer. 2011 Oct 15;117(20):4679-88. doi: 10.1002/cncr.26091. Epub 2011 Mar 31.

5.

IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes.

Poindexter NJ, Williams RR, Powis G, Jen E, Caudle AS, Chada S, Grimm EA.

Exp Dermatol. 2010 Aug;19(8):714-22. doi: 10.1111/j.1600-0625.2010.01077.x.

6.

IL-24 gene transfer sensitizes melanoma cells to erlotinib through modulation of the Apaf-1 and Akt signaling pathways.

Deng WG, Kwon J, Ekmekcioglu S, Poindexter NJ, Grimm EA.

Melanoma Res. 2011 Feb;21(1):44-56. doi: 10.1097/CMR.0b013e3283382155.

7.

Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells.

Zheng M, Bocangel D, Ramesh R, Ekmekcioglu S, Poindexter N, Grimm EA, Chada S.

Mol Cancer Ther. 2008 Dec;7(12):3842-51. doi: 10.1158/1535-7163.MCT-08-0516. Epub 2008 Dec 3.

8.

Soluble human MDA-7/IL-24: characterization of the molecular form(s) inhibiting tumor growth and stimulating monocytes.

Mumm JB, Ekmekcioglu S, Poindexter NJ, Chada S, Grimm EA.

J Interferon Cytokine Res. 2006 Dec;26(12):877-86.

PMID:
17238830
9.

WP760, a melanoma selective drug.

Zheng M, Priebe W, Walch ET, Roth KG, Han M, Tang CH, Lee S, Poindexter NJ, Fokt I, Grimm EA.

Cancer Chemother Pharmacol. 2007 Oct;60(5):625-33. Epub 2006 Dec 29.

PMID:
17195067
10.

Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10.

Zheng M, Bocangel D, Doneske B, Mhashilkar A, Ramesh R, Hunt KK, Ekmekcioglu S, Sutton RB, Poindexter N, Grimm EA, Chada S.

Cancer Immunol Immunother. 2007 Feb;56(2):205-15. Epub 2006 May 19.

PMID:
16710719
11.

Cytokine induction of interleukin-24 in human peripheral blood mononuclear cells.

Poindexter NJ, Walch ET, Chada S, Grimm EA.

J Leukoc Biol. 2005 Sep;78(3):745-52. Epub 2005 Jul 6.

PMID:
16000394
12.

Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer.

Poindexter NJ, Sahin A, Hunt KK, Grimm EA.

Breast Cancer Res. 2004;6(4):R408-15. Epub 2004 Jun 4.

13.

HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC.

Ellerhorst JA, Hildebrand WH, Cavett JW, Fernandez-Vina MA, Hodges S, Poindexter N, Fischer H, Grimm EA.

Urologe A. 2004 Sep;43 Suppl 3:S137. No abstract available.

PMID:
15148575
14.

MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.

Chada S, Sutton RB, Ekmekcioglu S, Ellerhorst J, Mumm JB, Leitner WW, Yang HY, Sahin AA, Hunt KK, Fuson KL, Poìndexter N, Roth JA, Ramesh R, Grimm EA, Mhashilkar AM.

Int Immunopharmacol. 2004 May;4(5):649-67. Review.

PMID:
15120650
15.

Heterozygosity or homozygosity for 2 HLA class II haplotypes predict favorable outcomes for renal cell carcinoma treated with cytokine therapy.

Ellerhorst JA, Hildebrand WH, Cavett JW, Fernandez-Vina MA, Hodges S, Poindexter N, Fischer H, Grimm EA.

J Urol. 2003 Jun;169(6):2084-8.

PMID:
12771724
16.

The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24.

Caudell EG, Mumm JB, Poindexter N, Ekmekcioglu S, Mhashilkar AM, Yang XH, Retter MW, Hill P, Chada S, Grimm EA.

J Immunol. 2002 Jun 15;168(12):6041-6.

17.

In vitro T cell proliferation from kidney allograft biopsies with unremarkable pathology: new strategies for an old problem.

Smith CR, Jaramillo A, Poindexter NJ, Steward NS, Lu KC, Brennan DC, Singer GG, Miller BW, Jendrisak MD, Shenoy S, Lowell JA, Howard TK, Mohanakumar T.

Transplantation. 2002 Jan 15;73(1):142-5.

PMID:
11792994
18.

Indirect recognition of porcine swine leukocyte Ag class I molecules expressed on islets by human CD4+ T lymphocytes.

Olack B, Manna P, Jaramillo A, Steward N, Swanson C, Kaesberg D, Poindexter N, Howard T, Mohanakumar T.

J Immunol. 2000 Aug 1;165(3):1294-9.

19.

Liver transplant recipient sera derived soluble HLA mediates allele specific CTL apoptosis.

Smith MA, Naziruddin B, Poindexter NJ, Haynes AE, Howard T, Mohanakumar T.

Transplantation. 2000 Jan 15;69(1):157-62.

PMID:
10653395
20.

Characterization of an HLA-A3 restricted human kidney specific T cell clone.

Poindexter NJ, Steward NS, Mohanakumar T.

Hum Immunol. 1999 Oct;60(10):939-43.

PMID:
10566593
21.

Regulatory function of human CD4+ cytolytic T lymphocytes.

Poindexter NJ, Smith MA, Haynes AE, Mohanakumar T.

Transpl Immunol. 1999 Mar;7(1):45-9.

PMID:
10375077
22.

Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome.

SivaSai KS, Smith MA, Poindexter NJ, Sundaresan SR, Trulock EP, Lynch JP, Cooper JD, Patterson GA, Mohanakumar T.

Transplantation. 1999 Apr 27;67(8):1094-8.

PMID:
10232557
23.

Analysis of the in vivo and in vitro response of human T cells to porcine islets.

Olack B, Poindexter N, Swanson C, Steward N, Howard T, Mohanakumar T.

Transplant Proc. 1999 Feb-Mar;31(1-2):648-9. No abstract available.

PMID:
10083279
24.

Function of CD4+ cytolytic T lymphocytes in lung allografts.

Poindexter NJ, Sundaresan RS, Cooper JD, Patterson GA, Mohanakumar T.

Transplant Proc. 1999 Feb-Mar;31(1-2):195-6. No abstract available.

PMID:
10083075
25.

Cytotoxic T lymphocytes directed against donor HLA class I antigens on airway epithelial cells are present in bronchoalveolar lavage fluid from lung transplant recipients during acute rejection.

Nakajima J, Poindexter NJ, Hillemeyer PB, Trulock EP, Cooper JD, Patterson GA, Mohanakumar T, Sundaresan RS.

J Thorac Cardiovasc Surg. 1999 Mar;117(3):565-71.

26.

Renal allograft infiltrating lymphocytes: frequency of tissue specific lymphocytes.

Poindexter NJ, Steward NS, Shenoy S, Brennan DC, Lowell J, Singer G, Howard T, Mohanakumar T.

Hum Immunol. 1997 Jul;55(2):140-7.

PMID:
9361965
27.

Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens.

Poindexter N, Shenoy S, Howard T, Flye MW, Mohanakumar T.

Clin Transplant. 1997 Jun;11(3):174-7.

PMID:
9193838
28.

Sensitization to HLA antigens in islet recipients with failing transplants.

Olack BJ, Swanson CJ, Flavin KS, Phelan D, Brennan DC, White NH, Lacy PE, Scharp DW, Poindexter N, Mohanakumar T.

Transplant Proc. 1997 Jun;29(4):2268-9. No abstract available.

PMID:
9193621
29.

Tissue-specific HLA class I restricted CTL are a significant subpopulation of graft-infiltrating lymphocytes during rejection.

Mohanakumar T, Poindexter N, Steward N, Shenoy S, Lowell J, Howard T.

Transplant Proc. 1997 Feb-Mar;29(1-2):87-8. No abstract available.

PMID:
9123166
30.

Cytolytic T lymphocytes from human renal allograft biopsies are tissue specific.

Poindexter NJ, Steward NS, Shenoy S, Jendrisak MD, Flye MW, Howard TK, Mohanakumar T.

Hum Immunol. 1995 Sep;44(1):43-9.

PMID:
8522454
31.

Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL.

Poindexter NJ, Naziruddin B, McCourt DW, Mohanakumar T.

J Immunol. 1995 Apr 15;154(8):3880-7.

PMID:
7535816
32.

Characterization of kidney-specific peptides and their role in renal allograft rejection.

Poindexter NJ, Naziruddin B, Oppat W, Flye MW, Mohanakumar T.

Transplant Proc. 1995 Feb;27(1):900-2. No abstract available.

PMID:
7879223
33.

Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.

Shiroki R, Poindexter NJ, Woodle ES, Hussain MS, Mohanakumar T, Scharp DW.

Transplantation. 1994 Jun 15;57(11):1555-62.

PMID:
8009588
34.

Rejection of human islet allografts in human lymphocyte-reconstituted severe combined immunodeficient mice.

Shiroki R, Poindexter NJ, Mohanakumar T, Scharp DW.

Transplant Proc. 1994 Apr;26(2):716-7. No abstract available.

PMID:
8171622
36.

A peripheral mechanism preserves self-tolerance to a secreted protein in transgenic mice.

Whiteley PJ, Poindexter NJ, Landon C, Kapp JA.

J Immunol. 1990 Sep 1;145(5):1376-81.

PMID:
1974565
37.

Modulation of enterotoxin binding and function in vitro and in vivo.

Donta ST, Damiano-Burbach P, Poindexter NJ.

J Infect Dis. 1988 Mar;157(3):557-64.

PMID:
2830346
38.

Binding of toxic-shock-syndrome toxin-1 to human peripheral blood mononuclear cells.

Poindexter NJ, Schlievert PM.

J Infect Dis. 1987 Jul;156(1):122-9.

PMID:
3598213
39.
41.

Comparison of the binding of cholera and Escherichia coli enterotoxins to Y1 adrenal cells.

Donta ST, Poindexter NJ, Ginsberg BH.

Biochemistry. 1982 Feb 16;21(4):660-4.

PMID:
7041963

Supplemental Content

Loading ...
Support Center